|
chinese |
16 |
|
pediatric |
12 |
|
children |
11 |
|
magnetic resonance imaging |
11 |
|
adult |
10 |
|
allergy |
10 |
|
asparaginase |
10 |
|
brain microstructure |
10 |
|
cognition |
10 |
|
diffusion kurtosis imaging |
10 |
|
functional outcome |
10 |
|
human leukocyte antigens |
10 |
|
hypersensitivity |
10 |
|
intracranial germ cell tumor |
10 |
|
molecular tumour board |
10 |
|
neurotoxicity |
10 |
|
next-generation sequencing |
10 |
|
precision oncology |
10 |
|
radiation therapy |
10 |
|
sequence-directed therapy |
10 |
|
congenital heart disease |
9 |
|
diffusion |
9 |
|
germ cells |
9 |
|
neurotoxicity syndromes |
9 |
|
dysmorphism |
8 |
|
phenotyping |
8 |
|
prenatal exome |
8 |
|
variants of unknown clinical significance |
8 |
|
relapse |
7 |
|
22q11.2 deletion syndrome (22q11.2ds) |
6 |
|
array comparative genomic hybridization |
6 |
|
conotruncal anomaly |
6 |
|
hepatoblastoma |
6 |
|
22q11.2 deletion |
5 |
|
cancer survivors |
5 |
|
craniopharyngioma |
5 |
|
health-related quality of life |
5 |
|
hepatitis b virus |
5 |
|
hepatocellular carcinoma |
5 |
|
intracranial germ cell tumors |
5 |
|
neurocognitive function |
5 |
|
performance status |
5 |
|
pretreatment extent of disease |
5 |
|
risk stratification |
5 |
|
surveillance |
5 |
|
vaccination |
5 |
|
aortic stenosis |
4 |
|
chromosome 17p13.3 |
4 |
|
chromosome aberration |
4 |
|
chromosome15q13.3 deletion |
4 |
|
chronic |
4 |
|
cyclosporin |
4 |
|
donor lymphocyte infusion |
4 |
|
graft versus tumor effect |
4 |
|
haploidentical |
4 |
|
haploidentical hematopoietic stem cell transplantation |
4 |
|
hematopoietic stem cell transplantation |
4 |
|
immune thrombocytopenia |
4 |
|
immunotherapy |
4 |
|
microcephaly |
4 |
|
microduplication |
4 |
|
neuroblastoma |
4 |
|
neurological complications |
4 |
|
posterior reversible encephalopathy syndrome |
4 |
|
prader-willi syndrome |
4 |
|
pulmonary interstitial glycogenosis |
4 |
|
total body irradiation |
4 |
|
transplant-related morbidity |
4 |
|
11c-acetate |
3 |
|
adolescent |
3 |
|
brain tumor |
3 |
|
cancer chemotherapy |
3 |
|
cancer epidemiology |
3 |
|
cancer incidence |
3 |
|
cancer treatment |
3 |
|
cardiotoxicity |
3 |
|
childhood cancer |
3 |
|
cultural awareness |
3 |
|
culture |
3 |
|
discourse analysis |
3 |
|
dysarthria |
3 |
|
empirical data |
3 |
|
endocrinopathy |
3 |
|
ependymoma |
3 |
|
extracellular matrix |
3 |
|
fibrosis |
3 |
|
genetic counseling |
3 |
|
hearing loss |
3 |
|
human papillomavirus vaccine |
3 |
|
international child health |
3 |
|
long-term complications |
3 |
|
medical education |
3 |
|
outcome |
3 |
|
positron emission tomography |
3 |
|
radiotherapy |
3 |
|
recurrence |
3 |
|
survivors |
3 |
|
asia |
2 |
|
basal ganglia |
2 |
|
biopsy |
2 |
|
bleomycin |
2 |
|
brain tumors |
2 |
|
calibrated integrated backscatter |
2 |
|
cardiooncology |
2 |
|
cardiovascular disease |
2 |
|
central nervous system |
2 |
|
central nervous system neoplasms |
2 |
|
central nervous system tumor |
2 |
|
chemotherapy regimen |
2 |
|
child |
2 |
|
childhood cancer survivors |
2 |
|
china |
2 |
|
chorionic gonadotropin |
2 |
|
choroid plexus |
2 |
|
cisplatin |
2 |
|
collaboration |
2 |
|
collaborative group |
2 |
|
cyclophosphamide |
2 |
|
disease progression |
2 |
|
dna |
2 |
|
epidemiology |
2 |
|
fatal outcome |
2 |
|
germ cell tumor |
2 |
|
infants |
2 |
|
left atrial mechanics |
2 |
|
low grade glioma |
2 |
|
medical sciences |
2 |
|
medulloblastoma |
2 |
|
multidisciplinary |
2 |
|
multi‐disciplinary team |
2 |
|
oncology |
2 |
|
pediatric cancer |
2 |
|
sepsis |
2 |
|
sex |
2 |
|
speckle tracking echocardiography |
2 |
|
strain |
2 |
|
teratoma |
2 |
|
three-dimensional echocardiography |
2 |
|
tissue doppler,stress echocardiography |
2 |
|
ultrasound |
2 |
|
ventricular function |
2 |
|
ventricular functional reserve |
2 |
|
adjuvant chemotherapy |
1 |
|
administration schedule |
1 |
|
alleles |
1 |
|
aneuploidy |
1 |
|
animals |
1 |
|
biological markers |
1 |
|
biomarkers |
1 |
|
brain third ventricle |
1 |
|
burn wound |
1 |
|
burns - pathology |
1 |
|
cancer |
1 |
|
cancer diagnosis |
1 |
|
cancer prognosis |
1 |
|
cancer survival |
1 |
|
cell nucleus |
1 |
|
cell-free dna |
1 |
|
central nervous system cancer |
1 |
|
cerebellum |
1 |
|
cerebrovascular disorders |
1 |
|
choroid plexus carcinoma |
1 |
|
choroid plexus neoplasms |
1 |
|
chromosomes |
1 |
|
cicatrix - pathology |
1 |
|
clinical trial |
1 |
|
collagen |
1 |
|
collagen type i - analysis |
1 |
|
consensus |
1 |
|
cytogenetics |
1 |
|
dicer1 |
1 |
|
dna methylation |
1 |
|
dna methylation profiling |
1 |
|
dna sequence |
1 |
|
elastin - analysis |
1 |
|
endocrine system diseases |
1 |
|
endoscopy |
1 |
|
epidermis - chemistry - pathology |
1 |
|
epigenetics |
1 |
|
female |
1 |
|
female adolescents |
1 |
|
fetus |
1 |
|
fibronectins - analysis |
1 |
|
fluorescence in situ hybridization |
1 |
|
ganglioneuroblastoma |
1 |
|
genes |
1 |
|
genetic |
1 |
|
genome |
1 |
|
genomics |
1 |
|
genotype |
1 |
|
glioblastoma |
1 |
|
hematoma |
1 |
|
hereditary |
1 |
|
heterogeneity |
1 |
|
high-dose methotrexate |
1 |
|
histopathology |
1 |
|
human papillomavirus (hpv) vaccines |
1 |
|
human papillomavirus vaccines |
1 |
|
humans |
1 |
|
hypothalamus |
1 |
|
imaging findings |
1 |
|
immunogenicity |
1 |
|
infancy |
1 |
|
infant |
1 |
|
liquid biopsy |
1 |
|
long-term follow-up |
1 |
|
low-grade glioma |
1 |
|
low‐grade glioma |
1 |
|
measurable residual disease |
1 |
|
methylation |
1 |
|
microrna processing |
1 |
|
microscopy, fluorescence, multiphoton - methods |
1 |
|
molecular groups |
1 |
|
molecular pathology |
1 |
|
molecular subgroups |
1 |
|
morbidities |
1 |
|
multi-photon microscope |
1 |
|
mutation |
1 |
|
neuro-oncology |
1 |
|
neuropsychological |
1 |
|
origin of life |
1 |
|
paraganglioma |
1 |
|
pediatric central nervous system tumors |
1 |
|
pediatrics |
1 |
|
pineal parenchymal tumors of intermediate differentiation |
1 |
|
pineoblastoma |
1 |
|
polymorphism |
1 |
|
prognostic factors |
1 |
|
safety |
1 |
|
scar |
1 |
|
sdhb |
1 |
|
second harmonic generation |
1 |
|
sheep |
1 |
|
spinal |
1 |
|
subdural |
1 |
|
swine |
1 |
|
tectal glioma |
1 |
|
tp53 |
1 |
|
transcription |
1 |
|
treatment |
1 |
|
treatment burden |
1 |
|
vagina |
1 |
